The Food and Drug Administration (FDA) has reportedly seized probiotic products from a Minnesota-based company, alleging that they are being marketed as drugs. UAS Laboratories, Inc. apparently claims that its dietary supplements “could treat or prevent colds, flu, respiratory infections, urinary tract infections, yeast infections, ulcers, and high cholesterol.” The agency previously warned the company that it was violating the law and found during a March 2011 inspection that the company continued to make these claims. According to FDA, the products are misbranded under the Federal Food, Drug, and Cosmetic Act because the labeling fails to include adequate directions for use. FDA also alleges that the company did not seek its approval under a new drug application process. See FDA News Release, June 7, 2011.